Vice President, Chief Financial Officer
Prior to joining Moleac, Jonathan was an Associate Director in Corporate Finance and Business Development with Aslan Pharmaceuticals. He oversaw the successful completion of a US$42M Nasdaq IPO in 2018, and multiple follow-on offerings totalling more than US$125M. Prior to Aslan, he was in the investment banking and equity research industry, last serving as the lead analyst covering healthcare and consumer with CIMB.
Jonathan holds an MPhil in Management degree from the University of Cambridge, and graduated with a Bachelor of Commerce (First Class Honours) from the University of Western Australia as the top student and a Philip Brown scholar under the Jean Rogerson scholarship.